Clinical trial
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NCT00089557 · NeurogesX, Industry · Terminated
Key facts
| NCT number | NCT00089557 |
|---|---|
| Title | An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain |
| Official title | An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain |
| Lead sponsor | NeurogesX, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Zoster, Neuralgia, Pain, HIV Infections, Peripheral Nervous System Diseases, Diabetic Neuropathies, Diabetes Mellitus, Polyneuropathies |
| Intervention type | Drug |
| Interventions | Capsaicin Dermal Patch |
| First posted | Aug 9, 2004 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: